Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Juan Francisco Grau-Bejar

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Therapeutic Advances in Medical Oncology|April 3, 2023
Advances in immunotherapy for cervical cancerJuan Francisco Grau-Bejar, Carmen Garcia-Duran, David Garcia-Illescas, et al.
Clinical Advances in Hematology & Oncology : H&O|April 8, 2024
Immunotherapy in the treatment of advanced or recurrent endometrial cancerJuan Francisco Grau-Bejar, Lorena Farinas-Madrid, Carmen García-Duran, et al.
Trends in Cancer|March 25, 2025
Molecular and clinical insights into early-onset endometrial cancerZimeng Wu, Zhe Hu, Qinlan Li, et al.
British Journal of Cancer|May 5, 2026
Changes in Cyclin E1 expression and CCNE1 amplification in high-grade ovarian carcinomas post-PARP inhibitor exposureAlexis Trecourt, Alexander Valent, Elisa Yaniz-Galende, et al.
Tumori|June 13, 2024
Multiple targets, germline <i>BRCA1</i> mutation and HRD in a lung cancer patient: Molecular considerations and treatment decision-makingFabiana Perrone, Francesco Facchinetti, Benedetta Pellegrino, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 2, 2024
Phase I Trial of First-line Bintrafusp Alfa in Patients with Locally Advanced or Persistent/Recurrent/Metastatic Cervical CancerAna Oaknin, Sharad A Ghamande, Yuka Kasamatsu, et al.
Journal for Immunotherapy of Cancer|July 2, 2024
Immune predictors of response to immune checkpoint inhibitors in mismatch repair-deficient endometrial cancerJuan Francisco Grau Bejar, Elisa Yaniz Galende, Qinghe Zeng, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Therapeutic Advances in Medical Oncology|April 3, 2023
Advances in immunotherapy for cervical cancerJuan Francisco Grau-Bejar, Carmen Garcia-Duran, David Garcia-Illescas, et al.
Clinical Advances in Hematology & Oncology : H&O|April 8, 2024
Immunotherapy in the treatment of advanced or recurrent endometrial cancerJuan Francisco Grau-Bejar, Lorena Farinas-Madrid, Carmen García-Duran, et al.
Trends in Cancer|March 25, 2025
Molecular and clinical insights into early-onset endometrial cancerZimeng Wu, Zhe Hu, Qinlan Li, et al.
British Journal of Cancer|May 5, 2026
Changes in Cyclin E1 expression and CCNE1 amplification in high-grade ovarian carcinomas post-PARP inhibitor exposureAlexis Trecourt, Alexander Valent, Elisa Yaniz-Galende, et al.
Tumori|June 13, 2024
Multiple targets, germline <i>BRCA1</i> mutation and HRD in a lung cancer patient: Molecular considerations and treatment decision-makingFabiana Perrone, Francesco Facchinetti, Benedetta Pellegrino, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 2, 2024
Phase I Trial of First-line Bintrafusp Alfa in Patients with Locally Advanced or Persistent/Recurrent/Metastatic Cervical CancerAna Oaknin, Sharad A Ghamande, Yuka Kasamatsu, et al.
Journal for Immunotherapy of Cancer|July 2, 2024
Immune predictors of response to immune checkpoint inhibitors in mismatch repair-deficient endometrial cancerJuan Francisco Grau Bejar, Elisa Yaniz Galende, Qinghe Zeng, et al.
Pageof 1